Patients with painful sensory neuropathy associated with Sjögren's syndrome-associated neuropathy often show severe neuropathic pain which is not relieved by conventional treatments.
To evaluate the effect of intravenous immunoglobulin (IVIg) therapy in the treatment of neuropathic pain associated with Sjögren's syndrome.
Patients and methods
We examined 5 patients affected by painful sensory neuropathy associated with Sjögren's syndrome. All patients were treated with IVIg (0.4 g/kg/day for 5 days) and pain rating was assessed by the Visual Analogue Scale (VAS).
All five patients showed a remarkable improvement in neuropathic pain following IVIg therapy. Pain, assessed by the determination of mean VAS score, was reduced by 73.4% from days 2–14 following treatment. The observed clinical improvement persisted for 2 to 6 months. One patient, examined by quantitative sensory testing (QST), showed an improvement of superficial sensory deficit accompanied by pain relief.
IVIg might be an effective treatment for pain in Sjögren's syndrome-associated neuropathy. Further studies should be done in a controlled, blind study.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Peripheral neuropathy associated with sicca complex.Neurology. 1997; 48: 855-862
- Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome.Ann Neurol. 1990; 27: 304-315
- The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement.Ann Intern Med. 1969; 70: 751-762
- Segmental anhidrosis in the spinal dermatomes in Sjögren's syndrome-associated neuropathy.Neurology. 1993; 43: 1820-1823
- The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy.Brain. 2005; 128: 2518-2534
- Vasculitic neuropathy in rheumatoid disease and Sjögren syndrome.Neurology. 1982; 32: 839-845
- Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjögren's syndrome-associated cases.J Neurol. 1993; 240: 1-7
- Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjögren's syndrome.J Neurol Neurosurg Psychiatry. 2006; 77: 967-969
- Revised Japanese diagnostic criteria for Sjögren's syndrome.in: Annual Report of Research Committee for Immune Disease. Japanese Ministry of Health and Welfare, Tokyo1999: 35-38
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group.Ann Rheum Dis. 2002; 61: 554-558
- Age associated axonal features in HNPP with 17p11.2 deletion in Japan.J Neurol Neurosurg Psychiatry. 2005; 76: 1109-1114
- The minimum clinically significant difference in visual analogue scale pain score dose not differ with severity of pain.Emerg Med J. 2001; 18: 205-207
- A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold.Neurology. 1993; 43: 1508-1512
- A standard test of heat-pain responses using CASE IV.J Neurol Sci. 1996; 136: 54-63
- Preferential loss of large lumbar primary sensory neurons in carcinomatous sensory neuropathy.Ann Neurol. 1986; 20: 102-104
- Non-length dependent small fibre neuropathy/ganglionopathy.J Neurol Neurosurg Psychiatry. 2008; 79: 113
- Small neurons may be preferentially affected in ganglionopathy.J Neurol Neurosurg Psychiatry. 2008; 79: 113
- Immunotherapy of idiopathic inflammatory neuropathies.Muscle Nerve. 2003; 28: 273-292
- Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis.Ann Rheum Dis. 2003; 62: 1221-1223
- Intravenous immunoglobulin therapy in sensory neuropathy associated Sjögren's syndrome.J Neurol Neurosurg Psychiatry. 1996; 60: 699
- Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin.Neurology. 2003; 60: 503-505
- Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases.Neurology. 1998; 51: S2-S8
- Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.J Neurosci. 2003; 23: 1026-1040
- Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin.J Neurosci. 2000; 20: 6289-6293
- TNF-alpha expression in painful and nonpainful neuropathies.Neurology. 2001; 56: 1371-1377
- Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha?.Neurology. 2005; 65: 311-313
Published online: January 27, 2009
Accepted: December 15, 2008
Received: October 21, 2008
© 2008 Elsevier B.V. Published by Elsevier Inc. All rights reserved.